{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:18:15Z","timestamp":1783045095992,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020742","name":"State Key Laboratory of Anti-Infective Drug Development","doi-asserted-by":"publisher","award":["2015DQ780357"],"award-info":[{"award-number":["2015DQ780357"]}],"id":[{"id":"10.13039\/100020742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.109959","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:07:01Z","timestamp":1778627221000},"page":"109959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available ROR\u03b3t inverse agonist"],"prefix":"10.1016","volume":"179","author":[{"given":"Wei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliff C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2026.109959_bb0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109959_bb0010","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.drudis.2014.04.012","article-title":"Inhibiting ROR\u03b3t\/Th17 Axis for autoimmune disorders","volume":"19","author":"Isono","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.109959_bb0015","series-title":"Annual Reports in Medicinal Chemistry","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-417150-3.00012-0","article-title":"Targeting the nuclear hormone receptor ROR\u03b3t for the treatment of autoimmune and inflammatory disorders","volume":"48","author":"Dhar","year":"2013"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109959_bb0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpha.2023.05.009","article-title":"Small molecule inhibitors of ROR\u03b3t for Th17 regulation in inflammatory and autoimmune diseases","volume":"13","author":"Jiuping","year":"2023","journal-title":"J. Pharm. Anal."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109959_bb0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2016.1153066","article-title":"Retinoid-related orphan receptor gamma t (ROR\u03b3t) inhibitors from vitae pharmaceuticals (WO2015116904) and structure proposal for their phase I candidate VTP-43742","volume":"26","author":"Christian","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109959_bb0030","first-page":"1","article-title":"ROR\u03b3t inhibitors as potential Back-ups for the phase II candidate VTP-43742 from vitae pharmaceuticals: patent evaluation of WO2016061160 and US20160122345","volume":"27","author":"Christian","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109959_bb0035","article-title":"Therapeutic suppression of pulmonary neutrophilia and allergic airway hyperresponsiveness by an ROR\u03b3t inverse agonist","volume":"4","author":"Gregory S.","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109959_bb0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.4046","article-title":"Transient inhibition of ROR-\u0393t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells","volume":"22","author":"David R.","year":"2016","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.bioorg.2026.109959_bb0045","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1016\/j.bmcl.2014.09.053","article-title":"Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for ROR\u03b2 and ROR\u03b3t","volume":"24","author":"Christian","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109959_bb0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bmc.2013.12.021","article-title":"Discovery of novel N-(5-(arylcarbonyl)thiazol-2-Yl)amides and N-(5-(arylcarbonyl)thiophen-2-Yl)amides as potent ROR\u03b3t inhibitors","volume":"22","author":"Yonghui","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2026.109959_bb0055","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.bmcl.2018.09.032","article-title":"Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (ROR\u03b3t) inhibitor, S18-000003","volume":"28","author":"Yoshikazu","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109959_bb0060","article-title":"Discovery of a novel ROR\u03b3 antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis","volume":"11","author":"Suxing","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109959_bb0065","series-title":"An ascending multiple dose study with VTP-43742 in healthy volunteers","year":"2018"},{"key":"10.1016\/j.bioorg.2026.109959_bb0070","series-title":"ClinicalTrials.Gov; U.S. National Institutes of Health","article-title":"An ascending multiple dose study with VTP-43742 in healthy volunteers and psoriatic patients","year":"2018"},{"key":"10.1016\/j.bioorg.2026.109959_bb0075","series-title":"In: 13th Winter Conference on Medicinal and Bioorganic Chemistry","first-page":"22","article-title":"Discovery of VTP-43742, a ROR\u03b3t inverse agonist for the treatment of psoriasis","author":"Zhuang","year":"2017"},{"issue":"13","key":"10.1016\/j.bioorg.2026.109959_bb0080","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/cmdc.201700278","article-title":"Structural states of ROR\u03b3t: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds","volume":"12","author":"Joerg","year":"2017","journal-title":"ChemMedChem"},{"issue":"24","key":"10.1016\/j.bioorg.2026.109959_bb0085","doi-asserted-by":"crossref","first-page":"10976","DOI":"10.1021\/acs.jmedchem.8b00588","article-title":"Combating autoimmune diseases with retinoic acid receptor-related orphan receptor-\u03b3 (ROR\u03b3 or RORc) inhibitors: hits and misses","volume":"61","author":"Vrajesh B.","year":"2018","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109959_bb0090","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Leslie","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109959_bb0095","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Barry","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109959_bb0100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes Jason","year":"2017","journal-title":"J. Invest. Dermatol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:47:06Z","timestamp":1783043226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S0045206826004955"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109959","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available ROR\u03b3t inverse agonist","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109959"}}